Antibody Drug Delivery Systems Production 
Roots Analysis
FEBRUARY 26, 2024
Having reported over 70% increase in revenues over the past 5-6 years, the market for biologically derived products is currently estimated to be worth more than USD 200 billion. Our Social Media Platform Web: [link] LinkedIn: [link] Twitter: [link] The post Subcutaneous Medications and Drug Delivery Systems appeared first on Blog.
Roots Analysis
AUGUST 8, 2023
Ligand-targeted Liposomes: These liposomes can be employed for site- specific targeting by attaching ligands (including antibodies, peptides, and carbohydrates) to their surface or to the terminal end of the attached PEG chains. The figure presents various methods used for liposome preparation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
MARCH 21, 2022
Subcutaneous drug delivery systems – the helping hand for patients. There has been a significant increase in the number of biologics, specifically the new generation molecules, such as monoclonal antibodies, in the late-stage clinical studies ( phase II / phase III ). Our Social Media Platform. Web: [link].
Roots Analysis
SEPTEMBER 13, 2023
Conjugation is the process of formation of a single, stable hybrid, wherein one of the entities is a molecule, such as protein, antibody, peptide and small molecule. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody.
Roots Analysis
FEBRUARY 26, 2024
Advances in drug discovery and development technologies / platforms have increased the likelihood of targeting a number of the aforementioned types of biological targets. As a result, novel product development opportunities have emerged and are likely to benefit both drug developers and investors alike.
Roots Analysis
FEBRUARY 14, 2023
This can be attributed to the fact that liposomes can actively target tumor tissues when used in combination with antibodies. These platforms have created an opportunity for the product developers to share their innovative ideas in this domain.
Roots Analysis
MARCH 13, 2022
In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. Our Social Media Platform.
Expert insights. Personalized for you.
52 
Let's personalize your content